MedTrace Logo

Reliability and Validity of Thai Calgary Depression Scale of Schizophrenia (CDSS)

NCT01590784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-07-28

No results posted yet for this study

Summary

Depression in patients with schizophrenia is common. Several factors was found to be associated with depression including medical illness, quality of life, positive symptoms, and typical antipsychotics. The Calgary depression scale of schizophrenia (CDSS) is commonly used for screening depression in schizophrenia,however; the Thai version of CDSS has not been validated.

This study aims to a.) test the reliability and validity of the Thai version of Calgary depression scale of schizophrenia (CDSS) and b.) identify the prevalence and factors associated with depression in patients with schizophrenia including quality of life, type of antipsychotic drugs, and severity of schizophrenia in 60 patients with schizophrenia at the Faculty of Medicine, Chiang Mai University, Thailand.

Conditions

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Principal Investigators

  • Sirijit Suttajit, MD, MSc · Chiang Mai University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-06-30
Completion
2014-11-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01590784 on ClinicalTrials.gov